BR0314139A - Derivados de 1,4-pirazina substituìdos - Google Patents

Derivados de 1,4-pirazina substituìdos

Info

Publication number
BR0314139A
BR0314139A BR0314139-0A BR0314139A BR0314139A BR 0314139 A BR0314139 A BR 0314139A BR 0314139 A BR0314139 A BR 0314139A BR 0314139 A BR0314139 A BR 0314139A
Authority
BR
Brazil
Prior art keywords
substituted
pyrazine derivatives
derivatives
pyrazine
anxiety
Prior art date
Application number
BR0314139-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Jeffrey W Corbett
Jian-Min Fu
Michael D Ennis
Kristine E Frank
Robert L Hoffman
Patrick R Verhoest
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BR0314139A publication Critical patent/BR0314139A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0314139-0A 2002-09-12 2003-08-27 Derivados de 1,4-pirazina substituìdos BR0314139A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41026102P 2002-09-12 2002-09-12
PCT/US2003/024805 WO2004024719A1 (en) 2002-09-12 2003-08-27 Substituted 1,4-pyrazine derivatives

Publications (1)

Publication Number Publication Date
BR0314139A true BR0314139A (pt) 2005-07-12

Family

ID=31994096

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314139-0A BR0314139A (pt) 2002-09-12 2003-08-27 Derivados de 1,4-pirazina substituìdos

Country Status (10)

Country Link
US (1) US20040116444A1 (cg-RX-API-DMAC10.html)
EP (1) EP1539736A1 (cg-RX-API-DMAC10.html)
JP (1) JP2006506350A (cg-RX-API-DMAC10.html)
AR (1) AR041125A1 (cg-RX-API-DMAC10.html)
AU (1) AU2003269949A1 (cg-RX-API-DMAC10.html)
BR (1) BR0314139A (cg-RX-API-DMAC10.html)
CA (1) CA2494975A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA05002418A (cg-RX-API-DMAC10.html)
TW (1) TW200503717A (cg-RX-API-DMAC10.html)
WO (1) WO2004024719A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05012082A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Compuestos como antagonistas del receptor crf1.
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
IL311645B2 (en) * 2016-07-12 2025-11-01 Revolution Medicines Inc 2,5- disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines asallosteric shp2 inhibitors
CN110446709B (zh) 2017-01-23 2023-09-12 锐新医药公司 作为变构shp2抑制剂的二环化合物
CA3051054A1 (en) 2017-01-23 2018-07-26 Revolution Medicines, Inc. Pyridine compounds as allosteric shp2 inhibitors
TWI852912B (zh) 2017-09-07 2024-08-21 美商銳新醫藥公司 Shp2抑制劑組合物以及治療癌症的方法
BR112020007058A2 (pt) 2017-10-12 2020-10-06 Revolution Medicines, Inc. compostos de piridina, pirazina, e triazina como inibidores de shp2 alostéricos
BR112020009757A2 (pt) 2017-12-15 2020-11-03 Revolution Medicines, Inc. compostos policíclicos como inibidores alostéricos de shp2
PL3788049T3 (pl) 2018-05-01 2023-06-19 Revolution Medicines, Inc. Połączone z C40, C28 i C32 analogi rapamycyny jako inhibitory mTOR
EP3788050B1 (en) 2018-05-01 2024-08-28 Revolution Medicines, Inc. C26-linked rapamycin analogs as mtor inhibitors
EP4531859A4 (en) 2022-05-25 2026-05-27 Revolution Medicines Inc CANCER TREATMENT METHODS USING AN MTOR INHIBITOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4270297A (en) * 1996-09-16 1998-04-02 Du Pont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
PA8467401A1 (es) * 1998-02-17 2000-09-29 Pfizer Prod Inc Procedimiento para tratar la insuficiencia cardiaca
IL139197A0 (en) * 1999-10-29 2001-11-25 Pfizer Prod Inc Use of corticotropin releasing factor antagonists and related compositions
ATE307121T1 (de) * 2000-02-16 2005-11-15 Neurogen Corp Substituierte arylpyrazine

Also Published As

Publication number Publication date
US20040116444A1 (en) 2004-06-17
AR041125A1 (es) 2005-05-04
TW200503717A (en) 2005-02-01
MXPA05002418A (es) 2005-05-27
CA2494975A1 (en) 2004-03-25
AU2003269949A1 (en) 2004-04-30
WO2004024719A1 (en) 2004-03-25
JP2006506350A (ja) 2006-02-23
EP1539736A1 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
DK1446387T3 (da) Substituerede aryl, 1,4-pyrazinderivater
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
DK0833839T3 (da) Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme
ATE264863T1 (de) 28-epirapaloge
ITRM20020264A0 (it) Articolo assorbente e procedimento per la sua fabbricazione.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
EP1474139A4 (en) 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 HEMMER FOR THE TREATMENT OF DIABETES, ADIPOSITAS AND DYSLIPIDEMIA
BR0215405A (pt) Composições e processos de uso de collajolie
BRPI0413449A (pt) compostos de quinoxalina
EP1624935A4 (en) ANTI-ADHESION COMPOUNDS AND USE METHOD THEREFOR
BR0212250B1 (pt) produto de cuidado pessoal.
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
SE9802729D0 (sv) Novel Compounds
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
NO20044898L (no) Nye etonogestrel estere
DE50310977D1 (de) Kompaktiertes menthol
EP1568691A4 (en) ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
TW200503717A (en) Substituted 1,4-pyrazine derivatives
BR0316544A (pt) Compostos calcilìticos
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
BRPI0411382A (pt) derivados de 2-aminobenzoil
NO20005548D0 (no) Mykobakterieinhibitorer
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.